(19)

(11)

EP 1 143 990 A2

(12)

(43) Date of publication: 17.10.2001 Bulletin 2001/42 (21) Application number: 00957306.4 (22) Date of filing: 07.08.2000

(51) International Patent Classification (IPC)7: A61K 38/00 (86) International application number: PCT/US0021/462 (87) International publication number: WO 0110/454 (15.02.2001 Gazette 2001/07)

(84) Designated Contracting States: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL Designated Extension States: AL LT LV MK RO SI (30) Priority: 06.08.1999 US 370390 (71) Applicant: Aventis Pharmaceuticals Inc. Bridgewater, NJ 08807-0800 (US)	(72) Inventors: AVRAMIS, Vassilios, L. Sylmar, CA 91342 (US) COHEN, Lewis Pottstown, PA 19465 (US) (74) Representative: Jones, Stephen Anthony  AdamsonJonesBroadway Business Centre32a Stoney Street Nottingham NG1 1LL Nottingham NG1 1LL (GB)
	Remarks: WIPO A3 publication data is not currently available.